Hyundai Motor Company

Yuhan Corporation

Kia Corporation

Kia Motors Corporation

Nano Cms Co., Ltd.

Jong Gyun Kim

Seong Cheol Jeong

Soo Yong Chung

Jun Hwan Kim

Hyun Ho Choi

Jae Won Jung

Dong Kyun Kim

Dohoon Kim

Hyun Ju

Tae Dong Han

Seong Ran Lee

Su Youn Nam

Sang Ho Oh

Byung Hyun Choi

Young Sung Lee

Kyeong Bae Kim

Woo Seob Shin

Minji Seo

Dae Jong Kim

Ki Hong Kim

Jun Young Park

Moo Young Song

Seul Gi Kim

Mi Kyeong Ju

Jeong Hyun Na

June Hyung Lee

Ju Young Park

Doo Hyun Kim

Jin Hyoung Lee

Shi Surk Kim

Se-Woong Oh

Jeong Ki Kang

Su Min Park

Young Hwan Kim

Se Woong Oh

Ju-Young Park

Jun Kyung Lee

Seyoung Lim

Suk Il Park

Seung Il Moon

Young Kyung Choi

Hyo Jin Park

Na Rae Lee

In Hwan Lim

Taewang Kim

Kee Hoon Moon

Young Man Lee

Woo Sung Lim

Su Jin Ahn

Han Na Hong

Hae Yong Jo

Ho Woong Kang

Seung Yub Shin

Sangmyoun Lim

The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.

Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same

An embodiment hydrogen supply system includes a fuel cell, a hydrogen supply line connected to an inlet side of an anode of the fuel cell, a discharge valve provided on an outlet side of the anode of the fuel cell to discharge exhaust gas of the anode of the fuel cell to an outside, and a controller configured to perform a hydrogen-line inspection mode to determine whether there is a leak in the fuel cell or the hydrogen supply line by cutting off air supply to the fuel cell, supplying hydrogen through the hydrogen supply line, and blocking the discharge valve, and opening the discharge valve to determine whether the discharge valve is defective in response to a determination that the fuel cell and the hydrogen supply line are normal.

Hydrogen supply system for fuel cell and inspection method thereof

A cold start control method and system for fuel cell vehicles determines when the fuel cell vehicle is started, whether the fuel cell vehicle enters a cold start mode. An estimated time estimated to be required until the stopped vehicle coolant temperature, which is measured in a state in which the fuel cell vehicle is stopped before being started, reaches a reference temperature is derived. The required time required from a point in time at which the stopped vehicle coolant temperature is measured to a point in time at which the fuel cell vehicle enters the cold start mode is derived. A target heating value is corrected according to a ration between the estimated time and the required time to derive a final target heating value. The heating value of the fuel cell stack is caused to reach the final target heating value.

Cold start control method and system for fuel cell vehicles

An operation controller of a fuel cell and an operation control method thereof in a system for generating a drive output through a fuel cell and a battery includes a processor for selectively performing a driving stop control of the fuel cell through an operation variable including a required drive output and a load weight.

Operation controller of fuel cell and operation control method thereof

A system for determining performance of a fuel cell stack may include a vehicle that collects a current of the fuel cell stack and a current of the fuel cell stack and a server that receives the voltage of the fuel cell stack and the current of the fuel cell stack from the vehicle in real time, determines an average state of health (SOH) of the fuel cell stack for each current section within an effective current range based on the current of the fuel cell stack and the voltage of the fuel cell stack within the effective current range, determines an overall average SOH in the effective current range based on the average SOH of the fuel cell stack for each current section, and determines whether the fuel cell stack has failed based on the overall average SOH.

System and method for determining performance of fuel cell stack

A device for diagnosing a valve failure of a fuel cell system is capable of accurately and quickly determining whether an integrated valve in a fuel cell system is operated abnormally, and preventing problems caused by the operation abnormality of the integrated valve.

Device for diagnosing valve failure of fuel cell system

Provided are a method and system for correcting an offset of a hydrogen pressure sensor. The method includes constantly supplying the hydrogen to the fuel cell stack, determining whether an offset of the hydrogen pressure sensor needs to be corrected based on a stop time before the fuel cell stack starts and a magnitude of an output voltage of the fuel cell stack, calculating an offset correction value when the offset of the hydrogen pressure sensor needs to be corrected, and correcting the offset of the hydrogen pressure sensor and performing the starting of the fuel cell stack.

Method and system for correcting offset of hydrogen pressure sensor

A control system and method for preventing a fuel cell from overheating are disclosed. The system includes: a fuel cell that generates electric power through reaction of fuel gas and oxidation gas; a cooling line in which a cooling medium flows and performs heat exchange with the fuel cell; a cooling pump installed on the cooling line and configured to circulate the cooling medium through the cooling line; a cooling controller that controls an operating state of the cooling pump on the basis of the temperature of the fuel cell or the cooling medium; and a power generation controller that limits power generation of the fuel cell on the basis of the operating state of the cooling pump.

Control system and method for preventing overheating of a fuel cell

A method for producing a dual function protein includes a biologically active protein and an FGF21 mutant protein. The method allows stable production of a target protein by effectively preventing decomposition of the target protein, and thus has a high potential for commercial usage.

Method for producing dual function proteins and its derivatives

A liquid level detecting apparatus of a tank for a vehicle is provided. The apparatus includes a main detecting part that detects the liquid level of the liquid in a tank to output a liquid level detection signal corresponding to the liquid level and an auxiliary floater assembly that has an auxiliary floater provided to float on the liquid surface of the liquid in the tank. A gyro sensor is mounted to the auxiliary floater, and an angle detection signal corresponding to an inclined angle of the tank is output by the gyro sensor. A controller determines a final liquid level value by correcting a liquid level value obtained from the liquid level detection signal based on the angle detection signal.

Liquid level detecting apparatus of tank for vehicle

The present disclosure relates to a method of recovering performance of a fuel cell stack in a fuel cell system of a vehicle. The method includes determining whether the fuel cell stack is in a state in which a stack performance recovery operation is possible based on information collected from the vehicle using a predetermined stack state determination criterion, determining whether the vehicle is in a state in which the stack performance recovery operation is possible based on operation information of a fuel cell system, and performing the stack performance recovery operation upon determining that the fuel cell stack is in the state in which the stack performance recovery operation is possible and that the vehicle is in the state in which the stack performance recovery operation is possible.

Method of recovering performance of fuel cell stack

The present invention relates to novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yppyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, a novel crystalline form thereof, and a process for preparing the same. More specifically, the present invention relates to mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide, which is excellent in stability, solubility, and bioavailability when it is administered not only alone but also in combination with other drugs and which has a high purity, a crystalline form thereof, and a process for preparing the same.

A fusion protein containing a biologically active protein and an FGF21 mutant protein, a pharmaceutical composition containing the fusion protein, and their uses are disclosed. The fusion protein and the pharmaceutical composition are effective in treating a liver disease including hepatitis, hepatic fibrosis, and hepatic cirrhosis. The fusion protein has effects of inhibiting proliferation of inflammatory cells and fibroblasts, and thus can be effectively used for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis.

Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis

The present invention provides a fusion protein comprising an FGF21 mutant protein and an Fc region of an immunoglobulin. The fusion protein according to the present invention exhibits improved pharmacological efficacy, in vivo duration and protein stability, and a pharmaceutical composition comprising the fusion protein as an active ingredient may be effectively used as a therapeutic agent for diabetes, obesity, dyslipidemia, metabolic syndrome, non-alcoholic fatty liver disease or non-alcoholic steatohepatitis.

Long-acting FGF21 fusion proteins and pharmaceutical composition comprising same

Growing community of inventors

Anyang-si, South Korea

Jong Gyun Kim